Literature DB >> 32420954

Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.

Matteo Gelardi1, Eleonora Trecca2, Michele Cassano3, Giorgio Ciprandi4.   

Abstract

In late December 2019, in Wuhan (China), health authorities reported several clusters of pneumo- nia of unknown cause, subsequently attributed to a novel coronavirus, identified as Severe Acute Respiratory Syndrome-Coronavirus 2. Anosmia and dysgeusia have been reported as particular symptoms.4,5  Notably, these sensory symptoms seem to have a peculiar trend, such as usually precede the onset of respiratory symp- toms. So, they have been defined as "sentinel" symptoms. We presented a series of COVID-19 patients. Anos- mia and dysgeusia frequently preceded respiratory complaints. Anosmia and dysgeusia seem to be short-lived and self-resolving in COVID-19, thus a neurotoxic effect swiftly disappearing and/or cytopathic damage could be hypothesized similarly to other viral infections.

Entities:  

Mesh:

Year:  2020        PMID: 32420954      PMCID: PMC7569643          DOI: 10.23750/abm.v91i2.9524

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


Sir, In late December 2019, in Wuhan (China), health authorities reported several clusters of pneumonia of unknown cause, subsequently attributed to a novel coronavirus, identified as Severe Acute Respiratory Syndrome-Coronavirus 2 (1). Due to the rapid worldwide spread of the outbreak, the World Health Organization declared that Coronavirus Disease-19 (COVID-19) was a global pandemic (2). Italy has been the first European country involved and has now the highest number of infected and dead patients. Vukkadala and colleagues provided a review to implement practical strategies (3). The main symptoms are fever, dry cough, dyspnea, myalgia, and headache. However, anosmia and dysgeusia have been reported as particular symptoms (4,5). Notably, these sensory symptoms seem to have a peculiar trend, such as usually precede the onset of respiratory symptoms. So, they have been defined as “sentinel” symptoms. In this regard, the European Rhinologic Society advised that patients with sudden onset loss of smell should be considered to be COVID-19 positive (www.europeanrhinologicsociety.org). However, smell and taste dysfunction usually disappear before the end of COVID-19. This particular characteristic is very dissimilar to anosmia consequent to another viral infectious rhinitis: in fact, some patients experience irreversible anosmia. Based on this background, we would present a preliminary report concerning a series of patients visited in Puglia in a primary care setting. The nasopharyngeal and oropharyngeal swab was performed in 89 patients. Real-time PCR was positive in 72 (81%) subjects. Therefore, only the 72 COVID-19 patients were analyzed. The mean age was 49.7 years (range 19-70 years), 39 males and 33 females. The main symptoms were fever (86%), cough (80%), breathlessness (47%), weakness (40%), headache (22%), myalgia (18%), nausea/vomiting (15%), diarrhea (11%), nasal congestion (7%). At present, 35 (49%) patients had clinical resolution; in these patients, the mean duration of symptoms was 22 days (range 8-29 days). Concerning sensory symptoms, isolated anosmia was perceived in 8 (11%), isolated dysgeusia in 18 (25%), and 34 (47%) patients reported both anosmia and dysgeusia; 12 (17%) patients had no sensory symptoms. The sensory symptoms preceded respiratory symptoms in 45 (75%) patients. The mean latent period between smell and taste dysfunction and the onset of respiratory symptoms was 2.8 days (range 1-4 days). Sensory symptoms completely disappeared in 22 (37%) patients, partially in 20 (33%), and unchanged in 18 (30%). The mean duration of sensory symptoms lasted 16.1 days (range 7-22 days). Of course, these data are still preliminary. Indeed, a large study is ongoing. Smell dysfunction is a common symptom in patients with nasal disorders, including infectious and inflammatory disease, mainly sustained by type 2 inflammation (6). Hypo/anosmia may be perceived also in patients with other problems, such as metabolic and neurologic diseases (7,8). Anosmia and dysgeusia seem to be short-lived and self-resolving in COVID-19, thus a neurotoxic effect swiftly disappearing and/or cytopathic damage could be hypothesized similarly to other viral infections (9). More experience should answer to these unmet needs.
  6 in total

Review 1.  COVID-19 and the Otolaryngologist: Preliminary Evidence-Based Review.

Authors:  Neelaysh Vukkadala; Z Jason Qian; F Christopher Holsinger; Zara M Patel; Eben Rosenthal
Journal:  Laryngoscope       Date:  2020-04-24       Impact factor: 3.325

2.  The association between diabetes and olfactory impairment in adults: A systematic review and meta-analysis.

Authors:  Sun Joo Kim; Melina J Windon; Sandra Y Lin
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-08-07

3.  Olfactory dysfunction in patients with chronic rhinosinusitis with nasal polyps is associated with clinical-cytological grading severity.

Authors:  M Gelardi; K Piccininni; N Quaranta; V Quaranta; M Silvestri; G Ciprandi
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-10       Impact factor: 2.124

4.  Screening performance of abbreviated versions of the UPSIT smell test.

Authors:  Theresita Joseph; Stephen D Auger; Luisa Peress; Daniel Rack; Jack Cuzick; Gavin Giovannoni; Andrew Lees; Anette E Schrag; Alastair J Noyce
Journal:  J Neurol       Date:  2019-05-03       Impact factor: 4.849

5.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

6.  Nasal cytology identifies healthy and damaged nasal epithelial cells - Reply.

Authors:  Giorgio Ciprandi; Matteo Gelardi
Journal:  Acta Biomed       Date:  2020-03-19
  6 in total
  19 in total

1.  Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.

Authors:  Mackenzie E Hannum; Riley J Koch; Vicente A Ramirez; Sarah S Marks; Aurora K Toskala; Riley D Herriman; Cailu Lin; Paule V Joseph; Danielle R Reed
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 3.160

2.  COVID-19 in Italy: The Point of View of the Italian Society of Pediatric Allergy and Immunology-COVID-19 Commission.

Authors:  Gian Luigi Marseglia; Elena Chiappini; Ilaria Brambilla; Amelia Licari; Maria Angela Tosca; Giorgio Ciprandi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-09-01       Impact factor: 0.885

3.  Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences.

Authors:  Christopher S von Bartheld; Molly M Hagen; Rafal Butowt
Journal:  ACS Chem Neurosci       Date:  2020-09-17       Impact factor: 4.418

Review 4.  Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review.

Authors:  A Boscutti; G Delvecchio; A Pigoni; G Cereda; V Ciappolino; M Bellani; P Fusar-Poli; P Brambilla
Journal:  Brain Behav Immun Health       Date:  2021-05-18

5.  COVID-19 lockdown and seasonal allergic rhinitis: our experience in 40 patients.

Authors:  Matteo Gelardi; Eleonora Trecca; Francesca Fortunato; Lucia Iannuzzi; Gianluca Ronca; Nicola Quaranta; Michele Cassano
Journal:  Acta Biomed       Date:  2021-05-12

6.  Is 2020 the golden year of Otolaryngology research? The impact of COVID-19 on the Italian academic production.

Authors:  Eleonora Trecca; Pier Gerardo Marano; Matteo Gelardi; Lazzaro Cassano; Giannandrea Francesco Verzicco; Aurelio D'Ecclesia; Michele Cassano; Francesco Longo
Journal:  Acta Biomed       Date:  2021-05-12

7.  Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19 positive patients compared to subjective methods: A systematic review and meta-analysis.

Authors:  Mackenzie E Hannum; Vicente A Ramirez; Sarah J Lipson; Riley D Herriman; Aurora K Toskala; Cailu Lin; Paule V Joseph; Danielle R Reed
Journal:  medRxiv       Date:  2020-07-06

8.  A Case of COVID-19 with Late-Onset Rash and Transient Loss of Taste and Smell in a 15-Year-Old Boy.

Authors:  Antonino Maniaci; Giannicola Iannella; Claudio Vicini; Piero Pavone; Giuseppe Nunnari; Raffaele Falsaperla; Paola Di Mauro; Salvatore Ferlito; Salvatore Cocuzza
Journal:  Am J Case Rep       Date:  2020-08-20

Review 9.  How to deal with coronavirus disease 2019: A comprehensive narrative review about oral involvement of the disease.

Authors:  Giorgia Capocasale; Riccardo Nocini; Paolo Faccioni; Dario Donadello; Dario Bertossi; Massimo Albanese; Francesca Zotti
Journal:  Clin Exp Dent Res       Date:  2020-10-05

10.  Parkinsonism as a Third Wave of the COVID-19 Pandemic?

Authors:  Leah C Beauchamp; David I Finkelstein; Ashley I Bush; Andrew H Evans; Kevin J Barnham
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.